Reporting of Randomized Clinical Trials Remains Far from Optimal

Masic I Miokovic M Muhamedagic B . Evidence based medicine—new approaches and challenges. Acta Inform Med. 2008;16:219–225.

Consort Group. Consort Statement: Transparent Reporting of Trials. http://www.consort-statement.org. Accessed February 2, 2018.

Begg C Cho M Eastwood S . Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637–639.

Moher D Schulz KF Altman DG : CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191–1194.

Moher D Hopewell S Schulz KF . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.

Ioannidis JP Evans SJ Gotzsche PC . Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141:781–788.

Turner L Shamseer L Altman DG . Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012;11: MR000030.

Magin P Victoire A Zhen XM . Under-reporting of socioeconomic status of patients in stroke trials: adherence to CONSORT principles. Stroke. 2013;44:2920–2922.

Maggi CB Griebeler IH da Silva Dal Pizzol T . Information on adverse events in randomised clinical trials assessing drug interventions published in four medical journals with high impact factors. Int J Risk Saf Med. 2014;26:9–22.

Camm CF Agha RA Edison E . CONSORT adherence in journals is still far from perfect. Ann Surg. 2015;261: e38.

Brænd AM Straand J Klovning A . Clinical drug trials in general practice: how well are external validity issues reported? BMC Fam Pract. 2017;18:113.

Kaper NM Swart KMA Grolman W Van Der Heijden GJMG . Quality of reporting and risk of bias in therapeutic otolaryngology publications. J Laryngol Otol. 2018;132:22–28.

Steinbrook R . Public registration of clinical trials. New Engl J Med. 2004;351:315–317.

www.ClinicalTrials.gov. Accessed February 2, 2018.

Riveros C Dechartres A Perrodeau E . Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med. 2013;10: e1001566.

Hartung DM Zarin DA Guise JM . Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med. 2014;160:477–483.

Tang E Ravaud P Riveros C Perrodeau E Dechartres A . Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles. BMC Med. 2015 14;13:189.

Katz DL . Clinical Epidemiology & Evidence-Based Medicine: Fundamental Principles of Clinical Reasoning & Research. Thousand Oaks, CA: Sage Publications.

Fuster V . Who truly benefits from pre-publishing and rushing publishing? Not patients, nor clinicians. J Am Coll Cardiol. 2017;70:3199–3200.

Bauchner H . The rush to publication: an editorial and scientific mistake. JAMA. 2017;318:1109–1110.

Turner JR . Update from the field of renal sympathetic denervation: a focus on safety nomenclature considerations. Therapeutic Innovation & Regulatory Science. 2017;51:664–668.